Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.40 |
| ▸ | MMP1 | P03956 | 4/20 | 0.38 |
| ▸ | MMP2 | P08253 | 3/20 | 0.38 |
| ▸ | MMP12 | P39900 | 3/20 | 0.38 |
| ▸ | MMP9 | P14780 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | GSK3A | P49840 | 3/20 | 0.36 |
| ▸ | RPS6KA3 | P51812 | 3/20 | 0.36 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.33 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.33 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.33 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5653895 | 0.87 | CYP1A1 (0.42) | CYP2D6CYP1B1MMP1MMP2MMP12 | |
| SCHEMBL5653660 | 0.82 | SMN1; SMN2 (0.42) | RAB9AMEN1KMT2ANPC1SMN1; SMN2 | |
| SCHEMBL5666340 | 0.81 | NLRP3 (0.39) | RAB9AMEN1KMT2ANPC1POLB | |
| SCHEMBL5653859 | 0.79 | L3MBTL1 (0.38) | RAB9AMEN1KMT2ANPC1SMN1; SMN2 | |
| SCHEMBL5654738 | 0.78 | ELANE (0.36) | MEN1KMT2ANPC1SMN1; SMN2L3MBTL1 | |
| SCHEMBL5652657 | 0.78 | CSNK2A2 (0.37) | MEN1KMT2APOLBCACNA1FABCB1 | |
| SCHEMBL5655350 | 0.78 | TGM2 (0.34) | RAB9AMEN1KMT2ANPC1CACNA1F | |
| SCHEMBL5654672 | 0.77 | ALDH1A1 (0.32) | MMP1MMP2MMP12MMP9RAB9A | |
| SCHEMBL14366922 | 0.76 | TDP1 (0.32) | MMP1MMP2MMP12MMP9MEN1 | |
| SCHEMBL5655473 | 0.74 | GABRP (0.35) | RAB9AMEN1KMT2ANPC1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070259948-A1 | Compounds with antifungal properties and process thereof | FDC LIMITED (IN) | 2007-11-08 | — | — | US | disclosed |
| US-20070259948-A1 | Compounds with antifungal properties and process thereof | FDC LIMITED (IN) | 2007-11-08 | — | — | US | disclosed |
| US-20070259948-A1 | Compounds with antifungal properties and process thereof | FDC LIMITED (IN) | 2007-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070259948-A1 | Compounds with antifungal properties and process thereof | ADH5, GK, AKR1C3 | CYP2D6 110/4885CYP1B1 73/4885MMP1 2993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.